Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 676 AL 690

Genetic variation in clusterin gene and Alzheimer's disease risk in Han Chinese

Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L.

Neurobiol Aging. 2013 Jul;34(7):1921.e17-23. doi: 10.1016/j.neurobiolaging.2013.01.010. Epub 2013 Feb 12.

Two cases of loss of consciousness after long-term memantine treatment

Savić A, Mimica N.

J Am Med Dir Assoc. 2013 May;14(5):375-6. doi: 10.1016/j.jamda.2013.01.010. Epub 2013 Feb 14.

Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool

Liu Y, Mattila J, Ruiz MÁ, Paajanen T, Koikkalainen J, van Gils M, Herukka SK, Waldemar G, Lötjönen J, Soininen H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e55246. doi: 10.1371/journal.pone.0055246. Epub 2013 Feb 12.

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

What can memory tests predict about the aging brain? The freedom to recall

Wright CB, Zonderman AB.

Neurology. 2013 Apr 2;80(14):1274-5. doi: 10.1212/WNL.0b013e31828ab392. Epub 2013 Mar 6.

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.

Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

Johansson P, Åberg D, Johansson JO, Mattsson N, Hansson O, Ahrén B, Isgaard J, Åberg ND, Blennow K, Zetterberg H, Wallin A, Svensson J.

Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6.

Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia

Mosconi L, Andrews RD, Matthews DC.

J Alzheimers Dis. 2013;35(3):509-24. doi: 10.3233/JAD-121867.

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease

Glodzik L, Randall C, Rusinek H, de Leon MJ.

J Alzheimers Dis. 2013;35(3):427-40. doi: 10.3233/JAD-122011.

Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults

Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K, Ashe KH.

JAMA Neurol. 2013 May;70(5):594-9. doi: 10.1001/jamaneurol.2013.48.

Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study

Takahashi R, Ishii K, Senda M, Ito K, Ishii K, Kato T, Makishi Y, Nishio T, Ikari Y, Iwatsubo T; Japanese Alzheimer’s Disease Neuroimaging Initiative.

Ann Nucl Med. 2013 Jun;27(5):452-9. doi: 10.1007/s12149-013-0704-x. Epub 2013 Mar 13.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Psychiatry looks towards the future in neurodegenerative and neurodevelopmental disorders

Sachdev PS.

Curr Opin Psychiatry. 2013 May;26(3):237-8. doi: 10.1097/YCO.0b013e32835fd70e.

Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population

Chin R, Ng A, Narasimhalu K, Kandiah N.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease

Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S.

J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias